Richesse EXO19

Richesse

Skin Booster

Liquid immune exosome skin booster for regenerative aesthetics

Formulated with FDA Approved ingredients according to manufacturer and distributor descriptions.
Produced by JDBIO Co., Ltd. under GMP Like quality standards and high Purity exosome refining processes.
Marketed as a professional cosmetic/aesthetic skin booster; regulatory classification (cosmetic vs. medical device) may vary by country and should be checked locally before clinical use.

Formulated with FDA Approved ingredients according to manufacturer and distributor descriptions.
Produced by JDBIO Co., Ltd. under GMP Like quality standards and high Purity exosome refining processes.
Marketed as a professional cosmetic/aesthetic skin booster; regulatory classification (cosmetic vs. medical device) may vary by country and should be checked locally before clinical use.
Intended only for professional use in compliance with local regulations governing exosome Based and regenerative aesthetic treatments.

Liquid immune exosome skin booster for regenerative aesthetics

Description

Richesse EXO19 is a next-generation liquid immune exosome skin booster engineered for intensive skin regeneration and repair. Powered by high-purity immune exosomes derived from advanced DLC (Dynamic Linked Cell) / TPC (TEXsome Progenitor Cell) technology, EXO19 delivers a concentrated dose of regenerative exosomes that work at a cellular level to accelerate skin repair, normalise skin function and improve barrier integrity. The fast-absorbing 2.2 ml ready-to-use serum contains 19 active ingredients, including hyaluronic acid, peptides, glutathione, niacinamide, sodium DNA (PN) and cica, formulated with FDA-approved ingredients. Clinically tested for skin regeneration, Richesse EXO19 demonstrates rapid cell migration, enhanced tissue recovery, improved skin barrier function and visible improvement in irritated or damaged skin within 24 hours of application. Suitable for professional skin booster protocols on the face, neck, décolletage, hands and other areas in need of regeneration, it supports smoother, brighter, more elastic and resilient skin with minimal downtime.

Bnefits

Utilises high-purity immune exosomes derived from advanced DLC / TPC technology to accelerate natural skin repair and regeneration.
Works at a cellular level to enhance cell communication, promoting collagen and elastin synthesis and improving overall skin quality.
Helps normalise skin function and strengthen the skin barrier, leading to a healthier, more resilient complexion.
Contains 19 active ingredients including hyaluronic acid, peptides, glutathione, sodium DNA (PN), niacinamide and cica for multi-dimensional anti-ageing and brightening effects.
Supports rapid tissue recovery and cell migration, with clinically observed improvement in irritated and damaged skin within 24 hours.
Improves skin texture, elasticity and radiance, addressing signs of ageing, dullness and uneven tone.
Contributes to stronger skin immunity and resistance to environmental stressors through immune exosome signalling and antioxidant components.
Fast-absorbing, ready-to-use liquid format ensures efficient penetration and easy integration into professional aesthetic protocols.
Produced using high-efficiency exosome manufacturing (up to 100x production capacity vs conventional methods) with high-purity refining and stringent quality control.
Designed for professional use in clinics as a high-performance skin booster, complementing other aesthetic procedures such as microneedling, mesotherapy and injectables.

Aestheticswarehouse

Richesse Collafilo

Aesthetic Injectables

£36.00
-1 more

Aestheticswarehouse

Richesse Eyes

Aesthetic Injectables

£30.00
-1 more

Aestheticswarehouse

Richesse Face

Aesthetic Injectables

£45.00
-1 more

Usage

For professional use only: Richesse EXO19 should be used exclusively by qualified medical or aesthetic practitioners trained in exosome-based skin booster protocols.
Prior to treatment, take a full medical history including skin conditions, allergies (especially to cosmetic actives, exosome formulations or any listed ingredients), medications and previous aesthetic procedures; obtain informed consent.
Cleanse the treatment area thoroughly and disinfect with an appropriate antiseptic according to clinic protocol.
Open the 2.2 ml vial aseptically; draw the required amount into a sterile syringe or device reservoir depending on the chosen delivery method.
Richesse EXO19 may be applied via professional techniques such as: microneedling (MTS) or stamping devices, superficial mesotherapy/nappage injections, or post-energy device topical application, according to clinic protocol and local regulations.
When using microneedling or stamping devices, adjust needle depth to a superficial to mid-dermal level appropriate for the indication and skin type, ensuring uniform coverage while avoiding excessive trauma.
If used with superficial injection techniques, inject small aliquots in a grid or linear pattern into the superficial dermis or subdermis per practitioner judgement; avoid intravascular injection and high-risk anatomical zones.
Distribute the product evenly across treatment areas such as face, neck, décolletage or hands, focussing on regions with more pronounced ageing or damage.
After application, gently massage or pat the skin if indicated by the chosen technique, and apply a soothing post-procedure product and broad-spectrum sunscreen where appropriate.
Typical protocols involve a series of sessions (for example, every 2–4 weeks for several treatments) depending on skin condition, with maintenance sessions scheduled as clinically appropriate.
Instruct patients to avoid makeup on the treated area for the rest of the day, minimise sun exposure, and avoid saunas, intense exercise and alcohol for 24–48 hours post-treatment, following clinic-specific aftercare guidance.
Discard any remaining product in an opened vial at the end of the session; exosome solutions are single-use and must not be stored for later use.
Dispose of all used needles, syringes and consumables in appropriate sharps and clinical waste containers.

Consentz Hub

Richesse EXO19

Description